微创医疗品牌怎么样 申请店铺

我要投票 微创医疗在精准医疗行业中的票数:289 更新时间:2025-04-03
微创医疗是哪个国家的品牌?「微创医疗」是上海微创医疗器械(集团)有限公司旗下著名品牌。该品牌发源于上海,由创始人常兆华在1998期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力微创医疗品牌出海!通过在本页面挂载微创医疗品牌的产品链接和联系邮箱,可以提高微创医疗产品曝光!跨境电商爆单神器,目前只要100元/年哦~

微创医疗怎么样

微创®起源于1998年成立的上海微创医疗器械(集团)有限公司,是一家中国出色的创新型医疗器械集团,总部位于中国上海张江科学城(上海市浦东新区张东路1601号) ,在中国上海、苏州、嘉兴、东莞,美国孟菲斯,法国巴黎近郊,意大利米兰近郊和多米尼加共和国等地均建有主要生产(研发)基地,形成了全球化的研发、生产、营销和服务网络。公司现有员工约5,000名,来自于30多个国家,其中过半数为中国员工。微创®专注于通过持续创新,为医生提供能挽救并重塑患者生命或改善其生活质量的真善美惠医疗解决方案。

微创®已上市产品约300个,覆盖心血管介入及结构性心脏病医疗、心脏节律管理及电生理医疗、骨科植入与修复、大动脉及外周血管介入、神经介入及脑科学、糖尿病及内分泌管理、泌尿及妇女健康、外科手术、医疗机器人与人工智能等十大业务集群。微创®的产品已进入全球逾8,000家医院,覆盖亚太、欧洲和美洲等主要地区。在全球范围内,平均每12秒就有一个微创®的产品被用于救治患者生命或改善其生活品质或用于帮助其催生新的生命。2014年推出的药物靶向洗脱支架系统更是令微创®在冠脉支架领域完成了从追随者和并跑者到全球带领者的跨越。

微创®人的创新动力源于一个属于患者和医生的品牌观,一切经营活动的理念和动机皆源自于患者,为了患者和用之于患者;一切创新的想法皆取之于医生,为了医生,并归之于医生。 “日月不以毫末而不照,雨露不以草草而不滋”,微创®人坚定地信仰人人都有生而平等的医疗权、健康权和追求活得更久的权利,并希冀与社会各界通力合作,为人人享有这种权利而积极创造各种各样的变革性医疗手段。微创®的远景(“以人为本,在以微创伤为代表的高科技医学领域建设一个属于患者的全球化医疗集团”)和使命(“持续创新,为医生提供能挽救并重塑患者生命或改善其生活质量的真善美惠医疗解决方案”)的核心就如同呼吸的空气、太阳的光芒和清晨的雨露一样,让代表全球高科技水平的医疗技术以公平、平等的方式,将健康和长寿带给世界上的每一个角落,每一个社区,每一个家庭和每一位患者。

秉承“致广致大致远致良知,尽精尽微尽心尽力”的管理理念,微创®在强调以人为本的同时,将对细节的追求和创新的坚持深深融入到企业基因之中。“患者和医生是并肩作战的战友,微创®是患者和医生的后勤保障,疾病是我们共同的敌人”,“为患者服务”和“为‘为患者服务的医生’服务”是微创®人共同的信仰。微创®人专注于与患者和医生结成命运共同体,缓解甚至消除各种慢性疾病对生命安全的严重威胁,并在把人类平均健康寿命提升至100岁、120岁甚至150岁的过程中,发挥越来越重要、甚至不可或缺的作用,为满足人类对“健康长寿”永无止境的美好追求做出重要贡献。


Minimally invasive ® originated from Shanghai minimally invasive medical devices (Group) Co., Ltd., established in 1998. It is an outstanding innovative medical device group in China. Its headquarter is located in Zhangjiang Science City, Shanghai, China (1601 Zhangdong Road, Pudong New Area, Shanghai). It is located in Shanghai, Suzhou, Jiaxing and Dongguan, China, Memphis, France, Paris, Milan, Italy and Dominican Republic And other places have established major production (R & D) bases, forming a global R & D, production, marketing and service network. The company has about 5000 employees, from more than 30 countries, of which more than half are Chinese employees. Minimally invasive ® focuses on providing doctors with true, good and beautiful medical solutions that can save and reshape patients' lives or improve their quality of life through continuous innovation. Minimally invasive ® has about 300 products on the market, covering ten business clusters, including cardiovascular intervention and structural heart disease medicine, cardiac rhythm management and electrophysiological medicine, orthopedic implantation and repair, large artery and peripheral vascular intervention, neural intervention and brain science, diabetes and endocrine management, urinary and women's health, surgical operation, medical robot and artificial intelligence. Minimally invasive products have entered more than 8000 hospitals around the world, covering major regions such as Asia Pacific, Europe and the Americas. Globally, on average, every 12 seconds, a minimally invasive ® product is used to treat patients' lives or improve their quality of life or to help them generate new lives. The drug-targeted eluting stent system launched in 2014 makes minimally invasive ® complete the leap from follower and parallel runner to global leader in the field of coronary stent. Minimally invasive ® people's innovation power comes from a brand concept belonging to patients and doctors. The concept and motivation of all business activities come from patients, for patients and for patients; all innovative ideas are taken from doctors, for doctors, and for doctors. "The sun and the moon don't shine, the rain and the dew don't nourish with grass and grass". Micro invasive people firmly believe that everyone has the right to health care, the right to health and the right to live longer, and hope to work together with all sectors of society to actively create a variety of transformative medical means for everyone to enjoy this right. Minimally invasive's vision ("people-oriented, building a global medical group for patients in the field of high-tech medicine represented by micro trauma") and mission ("continuous innovation, providing doctors with true, good and beautiful medical solutions that can save and reshape patients' lives or improve their quality of life") are like breathing air, sun light and morning rain In the same way, let the medical technology representing the global high-tech level bring health and longevity to every corner, every community, every family and every patient in a fair and equal way. Adhering to the management concept of "broad to the general, far to the conscience, meticulous to the utmost", micro invasive ® emphasizes people-oriented and deeply integrates the pursuit of details and innovation into the corporate gene. "Patients and doctors are comrades in arms, minimally invasive ® is the logistical support for patients and doctors, disease is our common enemy," serve patients "and" serve doctors for patients "are the common beliefs of minimally invasive ® people. Micro invasive people focus on forming a community of common destiny with patients and doctors to alleviate or even eliminate the serious threat of various chronic diseases to life safety, and play an increasingly important, even indispensable role in the process of raising the average healthy life of human beings to 100, 120 or even 150 years old, so as to make an important contribution to meet the endless pursuit of "healthy and long life" Offer.

本文链接: https://brand.waitui.com/c76f1c62f.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

证监会:进一步完善全链条全生命周期的多层次市场服务体系,加力支持优质民营企业做强做优做大

36氪获悉,证监会召开深化资本市场投融资综合改革民营科技企业座谈会。吴清强调,民营经济是国民经济的重要组成部分,是推动科技创新的重要力量。大力支持民营经济发展,既是资本市场服务实体经济的内在要求,也是加快培育高质量上市公司和促进资本市场高质量发展的重要着力点。尊重市场规律,切实提升资本市场的包容性、适应性,持续增强规则的透明度、可预期性,进一步完善全链条全生命周期的多层次市场服务体系,加力支持优质民营企业做强做优做大。

2小时前

吴清:民营科技企业作为民营经济和新质生产力领域的优秀代表,希望大家坚定信心,保持爱拼才会赢的精气神

证监会党委书记、主席吴清在北京召开专题座谈会,与集成电路、新能源汽车、智能制造、新材料、商业航天、网络经济等不同领域的民营科技企业代表深入交流。吴清强调,进一步完善全链条全生命周期的多层次市场服务体系,加力支持优质民营企业做强做优做大。民营科技企业作为民营经济和新质生产力领域的优秀代表,希望大家坚定信心,保持爱拼才会赢的精气神,以实际行动发挥好示范带头作用,积极利用资本市场转型升级、做优做强,更好回报投资者,为推动经济高质量发展和中国式现代化积极贡献力量。

2小时前

广汽集团:3月汽车销量173929辆,同比下降3.01%

36氪获悉,广汽集团公告,3月汽车销量173929辆,同比下降3.01%。其中新能源汽车销量33362辆,同比下降0.72%。

2小时前

盈富基金获南向资金净买入60.72亿港元

南向资金大幅净买入287.9亿港元,盈富基金、恒生中国企业、阿里巴巴-W分别获净买入60.72亿港元、48.33亿港元、34.87亿港元;申洲国际净卖出额居首,金额为0.12亿港元。(第一财经)

2小时前

保诚委任新区域执行总裁

保诚(Prudential)4月3日宣布,将委任蔡强为区域执行总裁,负责马来西亚、印尼及越南和代理人销售事务。现任区域执行总裁(高增长市场、健康保险及代理人销售)索尔马兹‧阿尔丁(Solmaz Altin)决定返回欧洲。蔡强将加入集团行政委员会,并常驻香港及向执行总裁华康尧(Anil Wadhwani)汇报,委任将于四月七日生效。(界面)

2小时前

本页详细列出关于康圣环球的品牌信息,含品牌所属公司介绍,康圣环球所处行业的品牌地位及优势。
咨询